- China
- /
- Aerospace & Defense
- /
- SHSE:688510
Additional Considerations Required While Assessing Wuxi HyatechLtd's (SHSE:688510) Strong Earnings
Wuxi Hyatech Co.,Ltd.'s (SHSE:688510) robust earnings report didn't manage to move the market for its stock. We did some digging, and we found some concerning factors in the details.
Check out our latest analysis for Wuxi HyatechLtd
Examining Cashflow Against Wuxi HyatechLtd's Earnings
One key financial ratio used to measure how well a company converts its profit to free cash flow (FCF) is the accrual ratio. To get the accrual ratio we first subtract FCF from profit for a period, and then divide that number by the average operating assets for the period. The ratio shows us how much a company's profit exceeds its FCF.
Therefore, it's actually considered a good thing when a company has a negative accrual ratio, but a bad thing if its accrual ratio is positive. While having an accrual ratio above zero is of little concern, we do think it's worth noting when a company has a relatively high accrual ratio. Notably, there is some academic evidence that suggests that a high accrual ratio is a bad sign for near-term profits, generally speaking.
Over the twelve months to September 2024, Wuxi HyatechLtd recorded an accrual ratio of 0.20. Unfortunately, that means its free cash flow fell significantly short of its reported profits. In the last twelve months it actually had negative free cash flow, with an outflow of CN¥99m despite its profit of CN¥113.5m, mentioned above. We also note that Wuxi HyatechLtd's free cash flow was actually negative last year as well, so we could understand if shareholders were bothered by its outflow of CN¥99m.
That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.
Our Take On Wuxi HyatechLtd's Profit Performance
Wuxi HyatechLtd's accrual ratio for the last twelve months signifies cash conversion is less than ideal, which is a negative when it comes to our view of its earnings. Therefore, it seems possible to us that Wuxi HyatechLtd's true underlying earnings power is actually less than its statutory profit. But the good news is that its EPS growth over the last three years has been very impressive. At the end of the day, it's essential to consider more than just the factors above, if you want to understand the company properly. So while earnings quality is important, it's equally important to consider the risks facing Wuxi HyatechLtd at this point in time. Every company has risks, and we've spotted 2 warning signs for Wuxi HyatechLtd (of which 1 doesn't sit too well with us!) you should know about.
This note has only looked at a single factor that sheds light on the nature of Wuxi HyatechLtd's profit. But there are plenty of other ways to inform your opinion of a company. For example, many people consider a high return on equity as an indication of favorable business economics, while others like to 'follow the money' and search out stocks that insiders are buying. While it might take a little research on your behalf, you may find this free collection of companies boasting high return on equity, or this list of stocks with significant insider holdings to be useful.
Valuation is complex, but we're here to simplify it.
Discover if Wuxi HyatechLtd might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About SHSE:688510
Wuxi HyatechLtd
Manufactures aero-engines and medical orthopedic implant forging system integration components.
High growth potential with excellent balance sheet.